TAT-HA2 Fusion Peptide |
Katalog-Nr.GC20218 |
Das TAT-HA2-Fusionspeptid ist ein auf Peptiden basierender Lieferant, der das pH-sensible HA2-Fusionspeptid von Influenza und das zellpenetrierende Peptid TAT von HIV kombiniert.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 923954-79-4
Sample solution is provided at 25 µL, 10mM.
TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV. TAT-HA2 Fusion Peptide induces the cellular uptake of macromolecules into endosomes via the TAT moiety and to respond to the acidifying lumen of endosomes to cause membrane leakage and release of macromolecules into cells via the HA2 moiety[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *